-
1
-
-
84863552263
-
Juvenile idiopathic arthritis
-
Espinosa, M. & Gottlieb, B. S. Juvenile idiopathic arthritis. Pediatr. Rev. 33, 303-313 (2012).
-
(2012)
Pediatr. Rev.
, vol.33
, pp. 303-313
-
-
Espinosa, M.1
Gottlieb, B.S.2
-
2
-
-
0017695324
-
Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis
-
Levinson, J. E. et al. Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis. J. Pediatr. 91, 799-804 (1977).
-
(1977)
J. Pediatr.
, vol.91
, pp. 799-804
-
-
Levinson, J.E.1
-
3
-
-
0028800309
-
Drug treatment in children with juvenile rheumatoid arthritis. Past, present, and future
-
Giannini, E. H. & Cawkwell, G. D. Drug treatment in children with juvenile rheumatoid arthritis. Past, present, and future. Pediatr. Clin. North Am. 42, 1099-1125 (1995).
-
(1995)
Pediatr. Clin. North Am.
, vol.42
, pp. 1099-1125
-
-
Giannini, E.H.1
Cawkwell, G.D.2
-
4
-
-
0019985236
-
Standard methodology for segment i II, and III pediatric rheumatology collaborative study group studies. I. Design
-
Brewer, E. J. & Giannini, E. H. Standard methodology for segment I, II, and III pediatric rheumatology collaborative study group studies. I. Design. J. Rheumatol. 9, 109-113 (1982).
-
(1982)
J. Rheumatol.
, vol.9
, pp. 109-113
-
-
Brewer, E.J.1
Giannini, E.H.2
-
5
-
-
0020328331
-
Standard methodology for segment i II, and III pediatric rheumatology collaborative study group studies. II. Analysis and presentation of data
-
Giannini, E. H. & Brewer, E. J. Standard methodology for segment I, II, and III pediatric rheumatology collaborative study group studies. II. Analysis and presentation of data. J. Rheumatol. 9, 114-122 (1982).
-
(1982)
J. Rheumatol.
, vol.9
, pp. 114-122
-
-
Giannini, E.H.1
Brewer, E.J.2
-
6
-
-
0021328911
-
Controlled trial of hydroxychloroquine and d-penicillamine singly and in combination in the treatment of rheumatoid arthritis
-
Bunch, T. W. et al. Controlled trial of hydroxychloroquine and d-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis Rheum. 27, 267-276 (1984).
-
(1984)
Arthritis Rheum
, vol.27
, pp. 267-276
-
-
Bunch, T.W.1
-
7
-
-
0022573025
-
Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial
-
Brewer, E. J., Giannini, E. H., Kuzmina, N. & Alekseev, L. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. N. Engl. J. Med. 314, 1269-1276 (1986).
-
(1986)
N. Engl. J. Med.
, vol.314
, pp. 1269-1276
-
-
Brewer, E.J.1
Giannini, E.H.2
Kuzmina, N.3
Alekseev, L.4
-
8
-
-
0025317654
-
Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled cooperative trial
-
The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group
-
Giannini, E. H., Brewer, E. J., Kuzmina, N., Shaikov, A. & Wallin, B. Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled cooperative trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group. Arthritis Rheum. 33, 466-476 (1990).
-
(1990)
Arthritis Rheum.
, vol.33
, pp. 466-476
-
-
Giannini, E.H.1
Brewer, E.J.2
Kuzmina, N.3
Shaikov, A.4
Wallin, B.5
-
9
-
-
0026579862
-
Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial
-
Williams, H. J. et al. Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum. 35, 1406-1407 (1992).
-
(1992)
Arthritis Rheum
, vol.35
, pp. 1406-1407
-
-
Williams, H.J.1
-
10
-
-
0026609159
-
Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial
-
The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group
-
Giannini, E. H. et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N. Engl. J. Med. 326, 1043-1049 (1992).
-
(1992)
N. Engl. J. Med.
, vol.326
, pp. 1043-1049
-
-
Giannini, E.H.1
-
11
-
-
3142746016
-
A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate
-
Ruperto, N. et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum. 50, 2191-2201 (2004).
-
(2004)
Arthritis Rheum.
, vol.50
, pp. 2191-2201
-
-
Ruperto, N.1
-
12
-
-
0030960980
-
Preliminary definition of improvement in juvenile arthritis
-
Giannini, E. H. et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 40, 1202-1209 (1997).
-
(1997)
Arthritis Rheum
, vol.40
, pp. 1202-1209
-
-
Giannini, E.H.1
-
13
-
-
80051741699
-
American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
-
Wallace, C. A. et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res. (Hoboken) 63, 929-936 (2011).
-
(2011)
Arthritis Care Res. (Hoboken)
, vol.63
, pp. 929-936
-
-
Wallace, C.A.1
-
14
-
-
0029982473
-
Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: A phase I/II study
-
Pediatric Rheumatology Collaborative Study Group
-
Giannini, E. H. et al. Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group. J. Rheumatol. 23, 919-924 (1996).
-
(1996)
J. Rheumatol.
, vol.23
, pp. 919-924
-
-
Giannini, E.H.1
-
15
-
-
0034673697
-
Etanercept in children with polyarticular juvenile rheumatoid arthritis
-
Pediatric Rheumatology Collaborative Study Group
-
Lovell, D. J. et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N. Engl. J. Med. 342, 763-769 (2000).
-
(2000)
N. Engl. J. Med.
, vol.342
, pp. 763-769
-
-
Lovell, D.J.1
-
16
-
-
84861815507
-
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis
-
Wallace, C. A. et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum. 64, 2012-2021 (2012).
-
(2012)
Arthritis Rheum
, vol.64
, pp. 2012-2021
-
-
Wallace, C.A.1
-
17
-
-
0032888041
-
A look at the future of pediatric therapeutics: An investigator's perspective of the new pediatric rule
-
Connor, J. D. A look at the future of pediatric therapeutics: an investigator's perspective of the new pediatric rule. Pediatrics 104, 610-613 (1999).
-
(1999)
Pediatrics
, vol.104
, pp. 610-613
-
-
Connor, J.D.1
-
18
-
-
85007680228
-
Use of unlabeled and off license drugs in children. A European paediatric rule is needed to protect children
-
Ruperto, N. & Martini, A. Use of unlabeled and off license drugs in children. A European paediatric rule is needed to protect children. BMJ 320, 1210-1211 (2000).
-
(2000)
BMJ
, vol.320
, pp. 1210-1211
-
-
Ruperto, N.1
Martini, A.2
-
19
-
-
33947432434
-
Regulation (EC) no 1901/2006 of the European parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004
-
European Parliament, Council
-
European Parliament, Council. Regulation (EC) no 1901/2006 of the European parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union 378, 1-19 (2006).
-
(2006)
Official Journal of the European Union
, vol.378
, pp. 1-19
-
-
-
20
-
-
10744230484
-
International league of associations for rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001
-
Petty, R. E. et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001. J. Rheumatol. 31, 390-392 (2004).
-
(2004)
J. Rheumatol.
, vol.31
, pp. 390-392
-
-
Petty, R.E.1
-
21
-
-
34848884299
-
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
-
Ruperto, N. et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 56, 3096-3106 (2007).
-
(2007)
Arthritis Rheum.
, vol.56
, pp. 3096-3106
-
-
Ruperto, N.1
-
22
-
-
49949115223
-
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
-
Lovell, D. J. et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N. Engl. J. Med. 359, 810-820 (2008).
-
(2008)
N. Engl. J. Med.
, vol.359
, pp. 810-820
-
-
Lovell, D.J.1
-
23
-
-
84883451142
-
-
US National Library Of Medicine. ClinicalTrials.gov
-
US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01230827 (2013).
-
(2013)
-
-
-
24
-
-
84883461426
-
-
US National Library Of Medicine. ClinicalTrials.gov
-
US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01550003 (2013).
-
(2013)
-
-
-
25
-
-
0029766227
-
Patterns of expression of tumor necrosis factor α, tumor necrosis factor β, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy
-
Grom, A. A. et al. Patterns of expression of tumor necrosis factor α, tumor necrosis factor β, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy. Arthritis Rheum. 39, 1703-1710 (1996).
-
(1996)
Arthritis Rheum
, vol.39
, pp. 1703-1710
-
-
Grom, A.A.1
-
26
-
-
9644255827
-
The German etanercept registry for treatment of juvenile idiopathic arthritis
-
Horneff, G. et al. The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann. Rheum. Dis. 63, 1638-1644 (2004).
-
(2004)
Ann. Rheum. Dis.
, vol.63
, pp. 1638-1644
-
-
Horneff, G.1
-
27
-
-
66149142293
-
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: The Dutch national register
-
Prince, F. H. et al. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann. Rheum. Dis. 68, 635-641 (2009).
-
(2009)
Ann. Rheum. Dis.
, vol.68
, pp. 635-641
-
-
Prince, F.H.1
-
28
-
-
78249250295
-
Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis
-
Giannini, E. H. et al. Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum. 62, 3259-3264 (2010).
-
(2010)
Arthritis Rheum
, vol.62
, pp. 3259-3264
-
-
Giannini, E.H.1
-
29
-
-
48349093002
-
Abatacept in children with juvenile idiopathic arthritis: A randomized, double-blind, placebo-controlled withdrawal trial
-
Ruperto, N. et al. Abatacept in children with juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled withdrawal trial. Lancet 372, 383-391 (2008).
-
(2008)
Lancet
, vol.372
, pp. 383-391
-
-
Ruperto, N.1
-
30
-
-
0034735842
-
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group
-
Lipsky, P. E. et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N. Engl. J. Med. 343, 1594-1602 (2000).
-
(2000)
N. Engl. J. Med.
, vol.343
, pp. 1594-1602
-
-
Lipsky, P.E.1
-
31
-
-
84883459745
-
-
European Medicines Agency, EPAR summary for the public: Humira
-
European Medicines Agency. EPAR summary for the public: Humira [online], http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Summary-for-the- public/human/000481/WC500050865.pdf (2013).
-
(2013)
-
-
-
32
-
-
79959370461
-
Juvenile idiopathic arthritis
-
.. Prakken, B., Albani, S. & Martini, A. Juvenile idiopathic arthritis. Lancet 377, 2138-2149 (2011).
-
(2011)
Lancet
, vol.377
, pp. 2138-2149
-
-
Prakken, B.1
Albani, S.2
Martini, A.3
-
33
-
-
0031993121
-
Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease?
-
De Benedetti, F. & Martini, A. Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? J. Rheumatol. 25, 203-207 (1998).
-
(1998)
J. Rheumatol.
, vol.25
, pp. 203-207
-
-
De Benedetti, F.1
Martini, A.2
-
34
-
-
18644385243
-
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
-
Pascual, V., Allantaz, F., Arce, E., Punaro, M. & Banchereau, J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J. Exp. Med. 201, 1479-1486 (2005).
-
(2005)
J. Exp. Med.
, vol.201
, pp. 1479-1486
-
-
Pascual, V.1
Allantaz, F.2
Arce, E.3
Punaro, M.4
Banchereau, J.5
-
35
-
-
77956526510
-
Tocilizumab: Molecular intervention therapy in children with systemic juvenile idiopathic arthritis
-
Yokota, S. & Kishimoto, T. Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis. Expert Rev. Clin. Immunol. 6, 735-743 (2010).
-
(2010)
Expert Rev. Clin. Immunol.
, vol.6
, pp. 735-743
-
-
Yokota, S.1
Kishimoto, T.2
-
36
-
-
84871318830
-
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis
-
De Benedetti, F. et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N. Engl. J. Med. 367, 2385-2395 (2012).
-
(2012)
N. Engl. J. Med.
, vol.367
, pp. 2385-2395
-
-
De Benedetti, F.1
-
37
-
-
79953323633
-
A multicenter, randomized, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
-
Quartier, P. et al. A multicenter, randomized, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann. Rheum. Dis. 70, 747-754 (2011).
-
(2011)
Ann. Rheum. Dis.
, vol.70
, pp. 747-754
-
-
Quartier, P.1
-
38
-
-
84856370186
-
A phase II study to evaluate dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
-
Ruperto, N. et al. A phase II study to evaluate dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. Arthritis Rheum. 64, 557-567 (2012).
-
(2012)
Arthritis Rheum.
, vol.64
, pp. 557-567
-
-
Ruperto, N.1
-
39
-
-
84871321221
-
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis
-
Ruperto, N. et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N. Engl. J. Med. 367, 2396-2407 (2012).
-
(2012)
N. Engl. J. Med.
, vol.367
, pp. 2396-2407
-
-
Ruperto, N.1
-
40
-
-
84871316266
-
A new era in the treatment of systemic juvenile idiopathic arthritis
-
Sandborg, C. & Mellins, E. D. A new era in the treatment of systemic juvenile idiopathic arthritis. N. Engl. J. Med. 367, 2439-2440 (2012).
-
(2012)
N. Engl. J. Med.
, vol.367
, pp. 2439-2440
-
-
Sandborg, C.1
Mellins, E.D.2
-
41
-
-
80051470174
-
Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): A multicenter randomized open-label clinical trial
-
Tynjala, P. et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicenter randomized open-label clinical trial. Ann. Rheum. Dis. 70, 1605-1612 (2011).
-
(2011)
Ann. Rheum. Dis.
, vol.70
, pp. 1605-1612
-
-
Tynjala, P.1
-
42
-
-
79957483535
-
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
-
Beukelman, T. et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. (Hoboken) 63, 465-482 (2011).
-
(2011)
Arthritis Care Res. (Hoboken)
, vol.63
, pp. 465-482
-
-
Beukelman, T.1
-
43
-
-
84883460572
-
Predictive markers of therapeutical outcome and their role in the ethiopathology of juvenile idiopathic arthritis [abstract]
-
Rossetti, M. et al. Predictive markers of therapeutical outcome and their role in the ethiopathology of juvenile idiopathic arthritis [abstract]. Arthritis Rheum. 64 (Suppl. 10), S1097-S1098 (2012).
-
(2012)
Arthritis Rheum.
, vol.64
, Issue.SUPPL. 10
-
-
Rossetti, M.1
-
44
-
-
77950512831
-
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: A randomized clinical trial
-
Foell, D. et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 303, 1266-1273 (2010).
-
(2010)
JAMA
, vol.303
, pp. 1266-1273
-
-
Foell, D.1
-
45
-
-
84868453277
-
Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: A comparative study
-
Gerss, J. et al. Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study. Ann. Rheum. Dis. 71, 1991-1997 (2012).
-
(2012)
Ann. Rheum. Dis.
, vol.71
, pp. 1991-1997
-
-
Gerss, J.1
-
46
-
-
85005769188
-
Summary of AHRQ's comparative effectiveness review of disease-modifying antirheumatic drugs for children with juvenile idiopathic arthritis
-
McMahan, R., Balfe, L. M. & Greene, L. Summary of AHRQ's comparative effectiveness review of disease-modifying antirheumatic drugs for children with juvenile idiopathic arthritis. J. Manag. Care Pharm. 18 (Suppl. B), 1-16 (2012).
-
(2012)
J. Manag. Care Pharm.
, vol.18
, Issue.SUPPL. B
, pp. 1-16
-
-
McMahan, R.1
Balfe, L.M.2
Greene, L.3
-
47
-
-
84863428204
-
Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis
-
DeWitt, E. M. et al. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res. (Hoboken) 64, 1001-1010 (2012).
-
(2012)
Arthritis Care Res. (Hoboken)
, vol.64
, pp. 1001-1010
-
-
Dewitt, E.M.1
-
48
-
-
84857227050
-
A european network of paediatric research at the european medicines agency (Enpr-EMA)
-
Ruperto, N. et al. A European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA). Arch. Dis. Child. 97, 185-188 (2012).
-
(2012)
Arch. Dis. Child.
, vol.97
, pp. 185-188
-
-
Ruperto, N.1
-
49
-
-
52649108201
-
Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis
-
Nielsen, S. et al. Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 26, 688-692 (2008).
-
(2008)
Clin. Exp. Rheumatol.
, vol.26
, pp. 688-692
-
-
Nielsen, S.1
-
50
-
-
77957584399
-
The safety profile of biologic therapies for juvenile idiopathic arthritis
-
Hashkes, P. J. Uziel, Y. & Laxer, R. M. The safety profile of biologic therapies for juvenile idiopathic arthritis. Nat. Rev. Rheumatol. 6, 561-571 (2010).
-
(2010)
Nat. Rev. Rheumatol.
, vol.6
, pp. 561-571
-
-
Hashkes, P.J.1
Uziel, Y.2
Laxer, R.M.3
-
51
-
-
77955371398
-
Tumor necrosis factor α blockers and malignancy in children: Forty-eight cases reported to the Food and Drug Administration
-
Diak, P. et al. Tumor necrosis factor α blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum. 62, 2517-2524 (2010).
-
(2010)
Arthritis Rheum
, vol.62
, pp. 2517-2524
-
-
Diak, P.1
-
52
-
-
84866175338
-
Rates of malignancy associated with juvenile idiopathic arthritis and its treatment
-
Beukelman, T. et al. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 64, 1263-1271 (2012).
-
(2012)
Arthritis Rheum
, vol.64
, pp. 1263-1271
-
-
Beukelman, T.1
-
53
-
-
78649648584
-
Juvenile idiopathic arthritis and risk of cancer: A nationwide cohort study
-
Simard, J., Neovius, M., Hagelberg, S. & Askling, J. Juvenile idiopathic arthritis and risk of cancer: A nationwide cohort study. Arthritis Rheum. 62, 3776-3782 (2010).
-
(2010)
Arthritis Rheum.
, vol.62
, pp. 3776-3782
-
-
Simard, J.1
Neovius, M.2
Hagelberg, S.3
Askling, J.4
-
54
-
-
78650990577
-
Pediatric rheumatology: JIA, treatment and possible risk of malignancies
-
Ruperto, N. & Martini, A. Pediatric rheumatology: JIA, treatment and possible risk of malignancies. Nat. Rev. Rheumatol. 7, 6-7 (2011).
-
(2011)
Nat. Rev. Rheumatol.
, vol.7
, pp. 6-7
-
-
Ruperto, N.1
Martini, A.2
-
55
-
-
79951691845
-
Report on malignancies in the German juvenile idiopathic arthritis registry
-
Horneff, G., Foeldvari, I., Minden, K., Moebius, D. & Hospach, T. Report on malignancies in the German juvenile idiopathic arthritis registry. Rheumatology (Oxford) 50, 230-236 (2011).
-
(2011)
Rheumatology (Oxford)
, vol.50
, pp. 230-236
-
-
Horneff, G.1
Foeldvari, I.2
Minden, K.3
Moebius, D.4
Hospach, T.5
-
56
-
-
79953317032
-
Malignancies in juvenile idiopathic arthritis: A preliminary report
-
Bernatsky, S. et al. Malignancies in juvenile idiopathic arthritis: a preliminary report. J. Rheumatol. 38, 760-763 (2011).
-
(2011)
J. Rheumatol.
, vol.38
, pp. 760-763
-
-
Bernatsky, S.1
|